ActivePhase 3ACTRN12607000556448
Contraceptive trial in healthy young women in which the use of a radiopaque etonogestrel implant inserted with a next generation applicator is evaluated.
An open-label, non-controlled multicentre trial to evaluate the insertion characteristics of the radiopaque etonogestrel implant using a next generation applicator.
Sponsor
NV Organon
Enrollment
300 participants
Start Date
Apr 23, 2007
Study Type
Interventional
Conditions
Eligibility
Sex: FemalesMin Age: 18 YearssMax Age: 40 Yearss
Plain Language Summary
Simplified for easier understanding
This study is about contraceptive trial in healthy young women in which the use of a radiopaque etonogestrel implant inserted with a next generation applicator is evaluated.. It is looking for adults aged 18 to 40 to participate. Participants will be guided through the study procedures by the research team and may need to attend scheduled visits.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Radiopaque Etonogestrel Implant for three years, no control treatment.
Radiopaque Etonogestrel Implant for three years, no control treatment.
Locations(3)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000556448
Related Trials
Influences of Long-acting Reversible Contraceptives on Iron Status and Physiological Responses to Extreme Environments in Women
NCT069096951 location
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
NCT054445828 locations
Kuwa Free! - Live Free!
NCT050449621 location
Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study
NCT063455601 location
Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study
NCT063455861 location